305 studies found for:    EPAS1
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Conditions: Childhood High-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Spinal Cord Neoplasm;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma
Interventions: Biological: bevacizumab;   Drug: irinotecan hydrochloride;   Radiation: fludeoxyglucose F 18
2 Completed Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Other: Picture + MMPs and TIMP1 at week 0 and week 4
3 Active, not recruiting Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine
Condition: Malaria
Interventions: Biological: Pfs25-EPA;   Biological: Euvax/Hepatitis B vaccine;   Biological: Menatra/Meningococcal Groups A, C, Y, W-135 vaccine;   Biological: Alhydrogel
4 Completed
Has Results
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
Conditions: Respiratory Distress Syndrome, Adult;   Acute Lung Injury;   Acute Respiratory Distress Syndrome
Intervention: Drug: Fish oil (eicosapentaenoic acid and docosahexanoic acid)
5 Completed
Has Results
Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Condition: Exudative Age-related Macular Degeneration.
Interventions: Dietary Supplement: Anti-VEGF plus AREDS-2;   Dietary Supplement: Anti-VEGF plus AREDS-1
6 Completed Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults
Conditions: Cognitive Function;   Mood
Interventions: Dietary Supplement: n-3 PUFAs;   Dietary Supplement: Placebo
7 Completed Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)
Condition: Malaria
Intervention: Biological: Pfs25-EPA/Alhydrogel
8 Completed
Has Results
Oxidized Omega-3 Supplements With Different Oxidation
Condition: Overweight
Interventions: Dietary Supplement: Less oxidized oil and diet;   Dietary Supplement: More oxidized oil and diet;   Drug: Hypercholesterolemic diet
9 Completed Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
Condition: Cardiovascular Disease
Interventions: Dietary Supplement: Fish Oil;   Dietary Supplement: Placebo
10 Completed Effect of Montelukast on Remodelling Markers in Asthmatic Children
Condition: Asthma
Interventions: Drug: Montelukast;   Drug: placebo
11 Completed A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
Condition: Healthy
Interventions: Drug: HCP1007;   Drug: Omarco and Crestor
12 Unknown  Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
Conditions: Mood Disorders;   Depression;   Combat Disorders;   Stress Disorders
Interventions: Drug: Lovaza, omega-3 fatty acid ethyl ester;   Drug: Placebo, visually identical to Lovaza
13 Completed Does Fish Oil Prevent Depression in Pregnancy and Postpartum?
Condition: Depression
Interventions: Drug: EPA-rich fish oil supplement;   Drug: DHA-rich fish oil supplement;   Drug: placebo
14 Completed Elevated Plasma Levels of TIMP-1 in Patients With Rotator Cuff Tear
Condition: Rotator Cuff Tear
Intervention: Procedure: Blood sampling
15 Active, not recruiting Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
Conditions: Schizophrenia;   Schizoaffective Disorder;   Major Depression;   Bipolar Disorder;   Coronary Artery Disease
Interventions: Drug: Eicosapentaenoic acid (omega-3 fatty acid);   Drug: Placebo
16 Completed Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
Condition: Shigellosis
Intervention: Biological: Shigella vaccine
17 Unknown  Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Fish Oil Supplementation;   Drug: Placebo Supplementation
18 Completed Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Docosahexaenoic acid;   Dietary Supplement: Docosahexaenoic acid (DHA)+ Eicosapentaenoic acid (EPA);   Dietary Supplement: Germ oil;   Other: National Cholesterol Education Program (NCEP) Step I Diet
19 Completed Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.
Conditions: LDL Cholesterol;   Triglycerides
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Investigational Product 1;   Dietary Supplement: Investigational Product 2
20 Recruiting Efficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Dietary Supplement: EPA and DHA supplementation;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years